BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18320146)

  • 21. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid as a cardiometabolic risk factor: to be or not to be.
    Kanbay M; Afsar B; Covic A
    Contrib Nephrol; 2011; 171():62-67. PubMed ID: 21625091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary hyperuricemia due to decreased renal uric acid excretion].
    Yamauchi T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):679-81. PubMed ID: 18409514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia, urate deposition and the association with hypertension.
    Mancia G; Grassi G; Borghi C
    Curr Med Res Opin; 2015; 31 Suppl 2():15-9. PubMed ID: 26414732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New-onset metabolic syndrome is associated with accelerated renal function decline partially through elevated uric acid: an epidemiological cohort study.
    Xu Q; Fan X; Chen G; Ma J; Ye W; Ai S; Wang L; Zheng K; Qin Y; Chen L; Li M; Li X
    Front Endocrinol (Lausanne); 2024; 15():1328404. PubMed ID: 38370360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between insulin resistance, metabolic syndrome components and serum uric acid.
    Adnan E; Rahman IA; Faridin HP
    Diabetes Metab Syndr; 2019; 13(3):2158-2162. PubMed ID: 31235151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome.
    Porchia LM; Gonzalez-Mejia ME; Torres-Rasgado E; Ruiz-Vivanco G; Pérez-Fuentes R
    Diabetes Metab Syndr; 2018 May; 12(3):325-331. PubMed ID: 29292186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients.
    Perez-Ruiz F; Aniel-Quiroga MA; Herrero-Beites AM; Chinchilla SP; Erauskin GG; Merriman T
    Rheumatol Int; 2015 Sep; 35(9):1519-24. PubMed ID: 25763991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
    Kojima S; Matsui K; Ogawa H; Jinnouchi H; Hiramitsu S; Hayashi T; Yokota N; Kawai N; Tokutake E; Uchiyama K; Sugawara M; Kakuda H; Wakasa Y; Mori H; Hisatome I; Waki M; Ohya Y; Kimura K; Saito Y;
    J Cardiol; 2017 Jan; 69(1):169-175. PubMed ID: 27005768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there anything good in uric acid?
    Alvarez-Lario B; Macarrón-Vicente J
    QJM; 2011 Dec; 104(12):1015-24. PubMed ID: 21908382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?
    Stellato D; Morrone LF; Di Giorgio C; Gesualdo L
    Intern Emerg Med; 2012 Feb; 7(1):5-8. PubMed ID: 21842242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid--a uremic toxin?
    Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
    Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid: bystander or culprit in hypertension and progressive renal disease?
    Menè P; Punzo G
    J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperuricemia and Cardiovascular Disease.
    Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
    Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uric acid, kidney disease and nephrolithiasis].
    Kim MJ; Hopfer H; Mayr M
    Ther Umsch; 2016; 73(3):159-65. PubMed ID: 27008449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between hyperuricemia and metabolic syndrome].
    Yamasaki T; Tomita K
    Nihon Rinsho; 2008 Apr; 66(4):766-70. PubMed ID: 18409529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperuricemia and renal risk].
    Viazzi F; Bonino B; Ratto E; Desideri G; Pontremoli R
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.